-
Product Insights
Ico Solar PV Park
Ico Solar PV Park is a solar PV project located in Ceara, Brazil. The project is owned and being developed by Lightsource BP Renewable Energy Investments Ltd. The project is at the permitting stage. Empower your strategies with our Ico Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Bertilimumab in Allergic Conjunctivitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bertilimumab in Allergic Conjunctivitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bertilimumab in Allergic Conjunctivitis Drug Details: Bertilimumab (Ico-008, CAT-213) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rozibafusp Alfa in Systemic Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rozibafusp Alfa in Systemic Lupus Erythematosus report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rozibafusp Alfa in Systemic Lupus Erythematosus Drug Details: Rozibafusp...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Acazicolcept in Systemic Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acazicolcept in Systemic Lupus Erythematosus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acazicolcept in Systemic Lupus Erythematosus Drug Details: Acazicolcept is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Acazicolcept in Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acazicolcept in Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acazicolcept in Arthritis Drug Details: Acazicolcept is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Acazicolcept in Type 1 Diabetes (Juvenile Diabetes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acazicolcept in Type 1 Diabetes (Juvenile Diabetes) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acazicolcept in Type 1 Diabetes (Juvenile Diabetes) Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Acazicolcept in Uveitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acazicolcept in Uveitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acazicolcept in Uveitis Drug Details: Acazicolcept is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Feladilimab in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Feladilimab in Cervical Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Feladilimab in Cervical Cancer Drug Details: GSK-3359609 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Feladilimab in Hypopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Feladilimab in Hypopharyngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Feladilimab in Hypopharyngeal Cancer Drug Details: GSK-3359609 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Feladilimab in Laryngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Feladilimab in Laryngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Feladilimab in Laryngeal Cancer Drug Details: GSK-3359609 is under development for...